PL2992899T3 - Wzmocniona odpowiedź immunologiczna u gatunków ptaków - Google Patents

Wzmocniona odpowiedź immunologiczna u gatunków ptaków

Info

Publication number
PL2992899T3
PL2992899T3 PL15178476T PL15178476T PL2992899T3 PL 2992899 T3 PL2992899 T3 PL 2992899T3 PL 15178476 T PL15178476 T PL 15178476T PL 15178476 T PL15178476 T PL 15178476T PL 2992899 T3 PL2992899 T3 PL 2992899T3
Authority
PL
Poland
Prior art keywords
immune response
avian species
enhanced immune
enhanced
avian
Prior art date
Application number
PL15178476T
Other languages
English (en)
Inventor
Albert Abraham
Original Assignee
Bayer Intellectual Property Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property Gmbh filed Critical Bayer Intellectual Property Gmbh
Publication of PL2992899T3 publication Critical patent/PL2992899T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15178476T 2009-05-14 2010-05-07 Wzmocniona odpowiedź immunologiczna u gatunków ptaków PL2992899T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17809909P 2009-05-14 2009-05-14
EP10720350.7A EP2429581B1 (en) 2009-05-14 2010-05-07 Enhanced immune response in avian species
PCT/EP2010/002809 WO2010130374A1 (en) 2009-05-14 2010-05-07 Enhanced immune response in avian species
EP15178476.6A EP2992899B1 (en) 2009-05-14 2010-05-07 Enhanced immune response in avian species

Publications (1)

Publication Number Publication Date
PL2992899T3 true PL2992899T3 (pl) 2021-04-06

Family

ID=42357738

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15178476T PL2992899T3 (pl) 2009-05-14 2010-05-07 Wzmocniona odpowiedź immunologiczna u gatunków ptaków
PL10720350T PL2429581T3 (pl) 2009-05-14 2010-05-07 Wzmocniona odpowiedź immunologiczna u gatunków ptaków

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL10720350T PL2429581T3 (pl) 2009-05-14 2010-05-07 Wzmocniona odpowiedź immunologiczna u gatunków ptaków

Country Status (34)

Country Link
US (1) US20120064151A1 (pl)
EP (2) EP2992899B1 (pl)
JP (1) JP5679589B2 (pl)
KR (2) KR20170102379A (pl)
CN (2) CN102427827B (pl)
AR (1) AR076767A1 (pl)
AU (1) AU2010246652B2 (pl)
BR (1) BRPI1010803A2 (pl)
CA (1) CA2761736C (pl)
CL (1) CL2011002808A1 (pl)
CO (1) CO6460752A2 (pl)
CR (1) CR20110595A (pl)
DK (2) DK2992899T3 (pl)
EC (1) ECSP11011448A (pl)
ES (2) ES2550181T3 (pl)
HR (2) HRP20151117T1 (pl)
HU (2) HUE025765T2 (pl)
IL (1) IL215900A (pl)
LT (1) LT2992899T (pl)
MX (1) MX336019B (pl)
MY (1) MY162561A (pl)
NI (1) NI201100196A (pl)
NZ (1) NZ596366A (pl)
PE (1) PE20120903A1 (pl)
PL (2) PL2992899T3 (pl)
PT (2) PT2992899T (pl)
RU (1) RU2570732C9 (pl)
SI (2) SI2992899T1 (pl)
SV (1) SV2011004056A (pl)
TW (1) TWI555846B (pl)
UA (1) UA106076C2 (pl)
UY (1) UY32634A (pl)
WO (1) WO2010130374A1 (pl)
ZA (1) ZA201107827B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0910036B8 (pt) * 2008-03-25 2021-05-25 Juvaris Biotherapeutics Inc kit compreendendo um primeiro administrador para via intra-venosa de um complexo de lipídio catiônico-dna (cldc) e um segundo administrador de uma vacina
SI2654785T1 (sl) * 2010-12-22 2019-06-28 Bayer Intellectual Property Gmbh Ojačan imunski odziv pri govejih vrstah
JO3733B1 (ar) 2011-04-05 2021-01-31 Bayer Ip Gmbh استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة
CN103721253B (zh) * 2014-01-02 2015-06-10 青岛易邦生物工程有限公司 一种禽脑脊髓炎和鸡痘二联活疫苗
CA2940794C (en) 2014-02-28 2022-05-31 Bayer Animal Health Gmbh Immunostimulatory plasmids
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
AU2016282879A1 (en) * 2015-06-26 2018-01-18 Bayer Animal Health Gmbh Methods of modulating cytosolic DNA surveillance molecules
DK3328423T3 (da) * 2015-07-31 2021-07-26 Bayer Animal Health Gmbh Forbedret immunrespons hos fisk
TW201718001A (zh) * 2015-07-31 2017-06-01 拜耳動物保健有限公司 豬物種中增強之免疫反應
US10933131B2 (en) 2016-07-26 2021-03-02 Bayer Animal Health Gmbh Increased fertility in bovine species
PL3700564T3 (pl) 2017-12-15 2026-02-23 Elanco Animal Health Gmbh Kompozycje immunostymulujące
CN114467855A (zh) * 2022-01-14 2022-05-13 广东海大集团股份有限公司 一种多病因气囊炎雏鸡模型的构建方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
DE60012711T2 (de) * 1999-03-26 2005-08-18 Vical, Inc., San Diego Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
EP1246848A1 (en) * 1999-12-27 2002-10-09 University Of Manitoba GENETIC VACCINES FOR THE PRODUCTION OF CHICKEN EGG-YOLK ANTIBODIES AGAINST ENTEROTOXIGENIC i ESCHERICHIA COLI /i AND OTHER PATHOGENS
US20050181035A1 (en) * 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
BRPI0910036B8 (pt) * 2008-03-25 2021-05-25 Juvaris Biotherapeutics Inc kit compreendendo um primeiro administrador para via intra-venosa de um complexo de lipídio catiônico-dna (cldc) e um segundo administrador de uma vacina

Also Published As

Publication number Publication date
EP2992899A1 (en) 2016-03-09
WO2010130374A1 (en) 2010-11-18
PT2992899T (pt) 2020-09-21
TW201043698A (en) 2010-12-16
IL215900A0 (en) 2012-01-31
UY32634A (es) 2010-12-31
NI201100196A (es) 2012-06-06
CN102427827B (zh) 2015-07-22
PL2429581T3 (pl) 2016-01-29
US20120064151A1 (en) 2012-03-15
KR20170102379A (ko) 2017-09-08
HUE025765T2 (en) 2016-05-30
CR20110595A (es) 2012-03-09
KR101966989B1 (ko) 2019-04-08
MX336019B (es) 2016-01-06
CO6460752A2 (es) 2012-06-15
ZA201107827B (en) 2012-12-27
MX2011011931A (es) 2011-12-06
SV2011004056A (es) 2012-03-14
DK2429581T3 (en) 2015-11-09
HRP20151117T1 (hr) 2015-11-20
CN102427827A (zh) 2012-04-25
AU2010246652A1 (en) 2011-11-17
HK1168032A1 (zh) 2012-12-21
KR20120027345A (ko) 2012-03-21
SI2429581T1 (sl) 2015-11-30
RU2011150529A (ru) 2013-06-20
JP2012526734A (ja) 2012-11-01
TWI555846B (zh) 2016-11-01
RU2570732C9 (ru) 2016-09-10
BRPI1010803A2 (pt) 2018-06-12
ES2550181T3 (es) 2015-11-05
NZ596366A (en) 2013-12-20
PT2429581E (pt) 2015-11-02
ECSP11011448A (es) 2011-12-30
ES2808827T3 (es) 2021-03-02
HRP20201554T1 (hr) 2020-12-11
CA2761736A1 (en) 2010-11-18
CN104906573A (zh) 2015-09-16
AR076767A1 (es) 2011-07-06
SI2992899T1 (sl) 2020-10-30
EP2992899B1 (en) 2020-07-01
RU2570732C2 (ru) 2015-12-10
DK2992899T3 (da) 2020-09-14
UA106076C2 (uk) 2014-07-25
IL215900A (en) 2017-07-31
EP2429581A1 (en) 2012-03-21
EP2429581B1 (en) 2015-08-05
CL2011002808A1 (es) 2012-07-13
MY162561A (en) 2017-06-30
AU2010246652B2 (en) 2014-10-02
PE20120903A1 (es) 2012-08-01
CA2761736C (en) 2017-09-26
JP5679589B2 (ja) 2015-03-04
LT2992899T (lt) 2020-10-26
HUE051005T2 (hu) 2021-01-28

Similar Documents

Publication Publication Date Title
IL215900A0 (en) Enhanced immune response in avian species
IL214403A0 (en) Novelcell lines and methods
PH12013501348A1 (en) Enhanced immune response in bovine species
EP2387850A4 (en) OBJECTS ASSOCIATED WITH A VIDEO
GB0917325D0 (en) Flavour enhancement
EP2435476A4 (en) ANTIBODIES OBTAINED FROM BIRDS
IT1398233B1 (it) Tostapane
GB0907935D0 (en) Vaccines
ZA201109283B (en) Protein
TWM372154U (en) Instant tree
EP2521787A4 (en) IMPROVED PROTEIN EXPRESSION
DK2269488T3 (da) Kaffemaskine
AU331093S (en) Toaster
GB0912202D0 (en) Bib
GB0900576D0 (en) Toaster
GB0909384D0 (en) Protein
ES1070232Y (es) Troceadora de pollos asados
PL118663U1 (pl) Skrzynka na listy
TWM370357U (en) Atmosphere teapot
TWM387604U (en) Wrist-protecting environmental-protection chopsticks
GB201016698D0 (en) Taste enhancement
GB0904698D0 (en) Cutlery
GB0903334D0 (en) Concept fifteen
GB0902993D0 (en) Mechanical tree
GB0902222D0 (en) Protein expression